Oxidative stress, molecular inflammation and sarcopenia

International Journal of Molecular Sciences

Volumn 11, Issue 4, 2010, Pages 1509-1526

  Meng, Si Jin ^a,b   Yu, Long Jiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN SPORTS UNIVERSITY   (China)

Author keywords

Chronic inflammation; Interventions; Oxidative stress; Sarcopenia; Signaling

Indexed keywords

ATROGIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MUSCLE RING FINGER 1 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN KINASE B; SOMATOMEDIN C; TRANSCRIPTION FACTOR FOXO;

AGING; APOPTOSIS; CALORIC RESTRICTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXERCISE; HUMAN; INFLAMMATION; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE STRENGTH; NONHUMAN; NUTRITION; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

CHRONIC INFLAMMATION; INTERVENTIONS; OXIDATIVE STRESS; SARCOPENIA; SIGNALING;

CALORIC RESTRICTION; EXERCISE; HUMANS; INFLAMMATION; MITOCHONDRIA, MUSCLE; OXIDATIVE STRESS; PROTEIN KINASES; SARCOPENIA; SIGNAL TRANSDUCTION;

EID: 77951922812     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms11041509     Document Type: Review

References (102)

1. Rosenberg, I.H. Sarcopenia: Origins and clinical relevance. J. Nutr. 1997, 127, 990S-991S.
2. Faulkner, J.A.; Larkin, L.M.; Claflin, D.R.; Brooks, S.V. Age-related changes in the structure and function of skeletal muscles. Clin. Exp. Pharmacol. Physiol. 2007, 34, 1091-1096.
3. Janssen, I.; Shepard, D.S.; Katzmarzyk, P.T.; Roubenoff, R. The healthcare costs of sarcopenia in the United States. J. Am. Geriatr. Soc. 2004, 52, 80-85.
4. Daw, C.K.; Starnes, J.W.; White, T.P. Muscle atrophy and hypoplasia with aging: Impact of training and food restriction. J. Appl. Physiol. 1988, 64, 2428-2432.
5. Lexell, J.; Taylor, C.C.; Sjostrom, M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J. Neurol. Sci. 1988, 84, 275-294.
6. Carter, C.S.; Hofer, T.; Seo, A.T.; Leeuwenburgh, C. Molecular mechanisms of life- and health- span extension: Role of calorie restriction and exercise intervention. Appl. Physiol. Nutr. Metab. 2007, 32, 954-966.
7. Kregel, K.C.; Zhang, H.J. An integrated view of oxidative stress in aging: Basic mechanisms, functional effects, and pathological considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292, R18-R36.
8. Siu, P.M.; Pistilli, E.E.; Alway, S.E. Age-dependent increase in oxidative stress in gastrocnemius muscle with unloading. J. Appl. Physiol. 2008, 105, 1695-705.
9. Moylan, J.S.; Reid, M.B. Oxidative stress, chronic disease, and muscle wasting. Muscle Nerve. 2007, 35, 411-429.
10. Samba, R.D.; Lauretani, F.; Ferrucci, L. Carotenoids as protection against sarcopenia in older adults. Arch. Biochem. Biophys. 2007, 458, 141-145.
11. Howard, C.; Ferrucci, L.; Sun, K.; Fried, L.P.; Walston, J.; Varadhan, R.; Guralnik, J.M.; Semba, R.D. Oxidative protein damage is associated with poor grip strength among older women living in the community. J. Appl. Physiol. 2007, 103, 17-20.
12. Koopman, R.; van Loon, L.J. Aging, exercise and muscle protein metabolism. J. Appl. Physiol. 2009, 106, 2040-2048.
13. Chung, H.Y.; Cesari, M.; Anton S.; Marzetti, E.; Giovannini, S.; Seo, A.Y.; Carter, C.; Yu, B.P.; Leeuwenburgh, C. Molecular inflammation: Underpinnings of aging and age-related diseases. Ageing Res. Rev. 2009, 8, 18-30.
14. Reid, M.B.; Li, Y.P. Tumor necrosis factor-α and muscle wasting: A cellular perspective. Respir. Res. 2001, 2, 269-272.
15. Brinkley, T.E.; Leng, X.; Miller, M.E.; Kitzman, D.W.; Pahor, M.; Berry, M.J.; Marsh, A.P.; Kritchevsky, S.B.; Nicklas, B.J. Chronic inflammation is associated with low physical function in older adults across multiple comorbidities. J. Gerontol. A. Biol. Sci. Med. Sci. 2009, 64, 455-461.
16. Toth, M.J.; Matthews, D.E.; Tracy, R.P.; Previs, M.J. Age-related differences in skeletal muscle protein synthesis: Relation to markers of immune activation. Am. J. Physiol. Endocrinol. Metab. 2005, 288, E883-E891.
17. Roubenoff, R. Catabolism of aging: Is it an inflammatory process? Curr. Opin. Clin. Nutr. Metab. Care. 2003, 6, 295-299.
18. Bua, E.; Johnson, J.; Herbst, A.; Delong, B.; McKenzie, D.; Salamat, S.; Aiken, J.M. Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers. Am. J. Hum. Genet. 2006, 79, 469-480.
19. Mariappan, N.; Elks, C.M.; Fink, B.; Francis, J. TNF-induced mitochondrial damage: A link between mitochondrial complex I activity and left ventricular dysfunction. Free Radic Biol. Med. 2009, 46, 462-470.
20. Figueiredo, P.A.; Mota, M.P.; Appell, H.J.; Duarte, J.A. The role of mitochondria in aging of skeletal muscle. Biogerontology 2008, 9, 67-84.
21. Marzetti, E.; Wohlgemutz, S.E.; Lees, H.A.; Chung, H.; Giovannini, S.; Leeuwenburgh, C. Age- related activation of mitochondrial caspase-independent apoptotic signaling in rat gastrocnemius muscle. Mech. Ageing Dev. 2008, 129, 542-549.
22. Rommel, C.; Bodine, S.C.; Clarke, B.A.; Rossman, R.; Nunez, L.; Stitt, T.N.; Yancopoulous, G.D.; Glass, D.J. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol. 2001, 3, 1009-1013.
23. Sacheck, J.M.; Ohtsuka, A.; McLary, S.C.; Goldberg, A.L. IGF-1 stimulates muscle growth by suppressing protein breakdown and expression of atrphy-related ubiquitin-ligases, atrogin-1 and MuRF1. Am. J. Physiol. Endocrinol. Metab. 2004, 287, E591-E601.
24. Li, M.; Li, C.; Parkhouse, W.S. Age-related differences in the des IGF-I-mediated activation of Akt-1 and p70 S6K in mouse skeletal muscle. Mech. Ageing Dev. 2003, 124, 771-778.
25. Lai, K.M.; Gonzalez, M.; Poueymirou, W.T.; Kline, W.O.; Na, E.; Zlotchenko, E.; Stitt, T.N.; Economides, A.N.; Yancopoulos, G.D.; Glass, D.J. Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol. Cell Biol. 2004, 24, 9295-9304.
26. Léger, B.; Cartoni, R.; Praz, M.; Lamon, S.; Dériaz, O.; Crettenand, A.; Gobelet, C.; Rohmer, P.; Konzelmann, M.; Luthi, F.; et al. Akt signaling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. J. Physiol. 2006, 576, 923-933.
27. Latres, E.; Amini, A.R.; Amini, A.A.; Griffiths, J.; Martin, F.J.; Wei, Y.; Lin, H.C.; Yancopoulous, G.D.; Glass, D.J. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J. Biol. Chem. 2005, 280, 2737-2744.
28. Bodine, S.C.; Stitt, T.N.; Gonzalez, M.; Kline, W.O.; Stover, G.L.; Bauerlein, R.; Zlotchenko, E.; Scrimgeour, A.; Lawrence, J.C.; Glass, D.J.; et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nature Cell Biol. 2001, 3, 1014-1019.
29. Bodine, S.C. mTOR signaling and the molecular adaptation to resistance exercise. Med. Sci. Sprots Exerc. 2006, 38, 1950-1957.
30. Koopman, R.; Zorenc, A.H.; Gransier, R.J.; Cameron-Smith, D.; van Loon L.J. Increase in S6K1 phosphorylation in human skeletal muscle following resistance exercise occurs mainly in type IImuscle fibers. Am. J. Physiol. Endocrinol. Metab. 2006, 290, E1245-E1252.
31. Owino, V.; Yang, S.Y.; Goldspink, G. Age-related loss of skeletal muscle function and the inability to express the autocrine form of insulin-like growth factor-1 (MGF) in response to mechanical overload. FEBS Lett. 2001, 505, 259-263.
32. Haddad, F.; Adams, G.R. Aging-sensitive cellular and molecular mechanisms associated with skeletal muscle hypertrophy. J. Appl. Physoil. 2006, 100, 1188-1203.
33. O'Connor, J.C.; McCusker, R.H.; Strle, K.; Johnson, R.W.; Dantzer, R; Kelley, K.W. Regulation of IGF-I Function by Proinflammatory Cytokines: At the Interface of Immunology and Endocrinology. Cell Immunol. 2008, 252, 91-110.
34. Papaconstantinou, J. Insulin/IGF-1 and ROS signaling pathway cross-talk in aging and longevity determination. Mol. Cell Endocrinol. 2009, 299, 89-100.
35. Grounds, M.D.; Radley, H.G.; Gebski, B.G.; Bogoyevitch, M.A.; Shavlakadze, T. Implications of cross-talk between TNF and IGF-1 signalling in skeletal muscle. Proc. Aust. Physiol. Soci. 2008, 39, 7-13.
36. Thomson, D.M.; Gordon, S.E. Impaired overload-induced muscle growth is associated with diminished translational signaling in aged rat fast-twitch skeletal muscle. J. Physiol. 2006, 574, 291-305.
37. Funai, F.; Parkington, J.D.; Carambula, S.; Fielding, R.A. Age associated decrease in contraction-induced activation of downstream targets of Akt/mTOR signaling in skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290, R1080-R1086.
38. Léger, B.; Bock, K.D.; Hespel, P.; Russell, A.P. Human sarcopenia reveals an increase in SOCS- 3 and myostatin and a reduced efficiency of akt phosphorylation. Rejuv. Res. 2008, 11, 163-175.
39. Marzani, B.; Balage, M.; Vénien, A.; Astruc, T.; Papet, I.; Dardevet, D.; Mosoni, L. Antioxidant Supplementation Restores Defective Leucine Stimulation of Protein Synthesis in Skeletal Muscle from Old Rats. J. Nutr. 2008, 138, 2205-2211.
40. Furukawa-Hibi, Y.; Kobayashi, Y.; Chen, C.; Motoyama, N. FOXO transcription factors in cell- cycle regulation and the response to oxidative stress. Antioxid Redox Signal. 2005, 7, 752-760.
41. Southgate, R.J.; Neill, B.; Prelovsek, O.; El-Osta, A.; Kamei, Y.; Miura, S.; Ezaki, O.; McLoughlin, T.J.; Zhang, W.; Unterman, T.G.; et al. FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle. J. Biol. Chem. 2007, 282, 21176-21186.
42. Kamei, Y.; Miura, S.; Suzuki, M.; Kai, Y.; Mizukami, J.; Taniguchi, T.; Mochida, K.; Hata, T.; Matsuda, J.; Aburatani, H.; et al. Skeletal muscle FOXO1(FKHR) transgenic mice have less skeletal muscle mass, down-regulated type I(slow twitch /red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem. 2004, 279, 41114-41123.
43. Stitt, T.N.; Drujan, D.; Clarke, B.A.; Panaro, F.; Timofeyva, Y.; Kline, W.O.; Gonzalez, M.; Yancopoulos, G.D.; Glass, D.J. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell. 2004, 14, 395-403.
44. Welle, S.; Brooks, A.I.; Delehanty, J.M.; Needler, N.; Thornton, C.A. Gene expression profile of aging in human muscle. Physiol. Genomics 2003, 14, 149-159.
45. Machida S.; Booth, F.W. Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals. Exp. Gerontol. 2004, 39, 1521-1525.
46. Sandri, M.; Sandri, C.; Gilbert, A.; Skurk, C.; Calabria, E.; Picard, A.; Walsh, K.; Schiaffino, S.; Lecker, S.H.; Goldberg, A.L. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117, 399-412.
47. Giresi, P.G.; Stevenson, E.J.; Theilhaber, J.; Koncarevic, A.; Parkington, J.; Fielding, R.A.; Kandarian, S.C. Identification of a molecular signature of sarcopenia. Physiol. Genomics 2005, 21, 253-263.
48. Piette, J.; Piret, B.; Bonizzi, G.; Schoonbroodt, S.; Merville, M.P.; Legrand-Poels, S.; Bours, V. Multiple redox regulation in NF- B transcription factor activation. Biol. Chem. 1997, 378, 1 237-1245.
49. Dogra C.; Changotra, H.; Mohan, S.; Kumar, A. Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein. J. Biol. Chem. 2006, 281, 10327-10336.
50. Mourkioti, F.; Kratsios, P.; Luedde, T.; Song, Y.; Delafontaine, P.; Adami, R.; Parente, V.; Bottinelli, R.; Pasparakis, M.; Rosenthal, N. Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J. Clin. Invest. 2006, 116, 2945-2954.
51. Hunter, R.B.; Kandarian, S.C. Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. J. Clin. Invest. 2004, 114, 1504-1511.
52. Urso, M.L.; Chen, Y.W.; Scrimgeour, A.G.; Lee, P.C.; Lee, K.F.; Clarkson, P.M. Alterations in mRNA expression and protein products following spinal cord injury in humans. J. Physiol. 2007, 579, 877-892.
53. Cuthbertson, D.; Smith, K.; Babraj, J.; Leese, G.; Waddell, T.; Atherton, P.; Wackerhage, H.; Taylor, P.M.; Rennie, M.J. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J. 2005, 19, 422-424.
54. Phillips, T.; Leeuwenburgh, C. Muscle fiber specific apoptosis and TNF-α signaling in sarcopenia are attenuated by life-long calorie restriction. FASEB J. 2005, 19, 668-670.
55. Li, Y.P.; Chen, Y.; John, J.; Moylan, J.; Jin, B.; Mann, D.L.; Reid, M.B. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J. 2005, 19, 362-370.
56. Gredinger, E.; Gerber, A.; Tamir, Y.; Tapscott, S.; Bengal, E. Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. J. Biol. Chem. 1998, 273, 10436-10444.
57. Musaro, A.; De Angelis, C.; Germani, A.; Ciccarelli, C.; Molinaro, M.; Zani B. Enhanced expression of myogenic regulatory genes in aging skeletal muscle. Exp. Cell Res. 1995, 221, 241-248.
58. Williamson, D.; Gallagher, P.; Harber, M.; Hollon, C.; Trappe, S. Mitogen-activated protein kinase (MAPK) pathway activation: Effects of age and acute exercise on human skeletal muscle. J. Physiol. 2003, 547, 977-987.
59. Drummond, M.J.; Dreyer, H.C.; Pennings, B.; Fry, CS.; Dhanani, S.; Dillon, E.L.; Sheffield- Moore, M.; Volpi, E.; Rasmussen, B.B. Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging. J. Appl. Physiol. 2008, 104, 1452-1461.
60. Raingeaud, J.; Gupta, S.; Rogers, J.; Dickens, M.; Han, J.; Ulevitch, R.J.; Davis, R.J. Pro- inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 1995, 270, 7420-7426.
61. Shen, H.M.; Liu, Z.G. JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic. Biol. Med. 2006, 40, 928-939.
62. Braga, M.; Sinha-Hikim, A.P.; Datta, S.; Ferrini, M.G.; Brown, D.; Kovacheva, E.L.; Gonzalez- Cadavid, N.F.; Sinha-Hikim, I. Involvement of oxidative stress and caspase 2-mediated intrinsic pathway signaling in age-related increase in muscle cell apoptosis in mice. Apoptosis 2008, 13, 822-832.
63. Glass, D.J. Skeletal muscle hypertrophy and atrophy signaling pathways. Int. J. Biochem. Cell Biol. 2005, 37, 1974-1984.
64. Bodine, S.C.; Latres, E.; Baumhueter, S.; Lai, V.K.; Nunez, L.; Clarke, B.A.; Poueymirou, W.T.; Panaro, F.J.; Na, E.; Dharmarajan, K.et al; Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001, 294, 1704-1708.
65. Li, H.H.; Kedar, V.; Zhang, C.; Arya, R.; Wang, D.Z.; Patterson, C. Atrogin-1/muscle atrophy F- box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J. Clin. Invest. 2004, 114, 1058-1071.
66. Stitt, T.N.; Drujan, D.; Clarke, B.A.; Panaro, F.J.; Timofeyva, Y.; Kline, W.O.; Gonzalez, M.; Yancopoulos, G.D.; Glass, D.J. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 2004, 14, 395-403.
67. Cai, D.; Frantz, J.D.; Tawa, N.E., Jr.; Melendez, P.A.; Oh, B.; Lidov, H.G.W.; Hasselgren, P.; Frontera, W.R.; Lee, J.; Glass, D.J.; et al.; IKKb/NF-kB activation causes severe muscle wasting in mice. Cell 2004, 119, 285-298.
68. Clavel, S.; Coldefy, A.S.; Kurkdjian, E.; Salles, J.; Margaritis, I.; Derijard, B. Atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 are up-regulated in aged rat tibialis anterior muscle. Mech. Ageing Dev. 2006, 127, 794-801.
69. Edstrom, E.; Altun, M.; Hagglund, M.; Ulfhake, B. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. J. Gerontol. A: Biol. Sci. Med. Sci. 2006, 61, 663-674.
70. Whitman, S.A.; Wacker, M.J.; Richmond, S.R.; Godard, M.P. Contributions of the ubiquitin- proteasome pathway and apoptosis to human skeletal muscle wasting with age. Pflugers Arch. 2005, 450, 437-446.
71. Raue, U.; Slivka, D.; Jemiolo, B.; Hollon, C.; Trappe, S. Proteolytic gene expression differs at rest and after resistance exercise between young and old women. J. Gerontol. A Biol. Sci. Med. Sci. 2007, 62, 1407-1412.
72. Christoph, H.; Spiegelman, M. The role of exercise and PGC1α in inflammation and chronic disease. Nature 2008, 454, 463-469.
73. Ventura-Clapier, R.; Garnier, A.; Veksler, V. Transcriptional control of mitochondrial biogenesis: The central role of PGC-1α. Cardiovasc. Res. 2008, 79, 208-217.
74. Sandri, M.; Lin, J.; Handschin, C.; Yang, W.; Arany, Z.P.; Lecker, S.H.; Goldberg, A.L.; Spiegelman, B.M. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc. Natl. Acad. Sci. USA 2006, 103, 16260-16265.
75. Handschin, C.; Kobayashi, Y.M.; Chin, S.; Seale, P.; Campbell, K.P.; Spiegelman, B.M. PGC- 1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes Dev. 2007, 21, 770-783.
76. St-Pierre, J.; Drori, S.; Uldry, M.; Silvaggi, J.M.; Rhee, J.; Jäger, S.; Handschin, C.; Zheng, K.; Lin, K.; Yang, W.; et al. Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators. Cell 2006, 127, 397-408.
77. Hood, D.A.; Irrcher, I.; Ljubicic, V.; Joseph, A.M. Coordination of metabolic plasticity in skeletal muscle. J. Exp. Bio. 2006, 209, 2265-2275.
78. Jager, S.; Handschin, C.; St-Pierre, J.; Spiegelman, B.M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. USA 2007, 104, 12017-12022.
79. Chabi, B.; Ljubicic, V.; Menzies, K.J.; Huang, J.H.; Sallem, A.; Hood, D.A. Mitochondrial function and apoptotic susceptibility in aging skeletal muscle. Aging Cell 2008, 7, 2-12.
80. López-Lluch, G.; Irusta, P.M.; Navas, P.; de Cabo, R. Mitochondrial biogenesis and healthy aging. Exp. Gerontol. 2008, 43, 813-819.
81. Leeuwenburgh, C. Role of apoptosis in sarcopenia. J. Gerontol. Med. Sci. 2003, 58, 999-1001.
82. Nitahara, J.A.; Cheng, W.; Liu, Y.; Li, B.; Leri, A.; Mogul, D.; Gambert, S.R.; Kajstura, J.; Anversa, P. Intracellular calcium, DNase activity and myocyte apoptosis in aging Fischer 344 rats. J. Mol. Cell. Cardiol. 1998, 30, 519-535.
83. Cadenas, E.; Davies, K.J. Mitochondrial free radical generation, oxidative stress, and aging. Free Rad. Biol. Med. 2000, 29, 222-230.
84. Song, W.; Kwak, H.; Lawler, J.M. Exercise training attenuates age-induced changes in apoptotic signaling in rat skeletal muscle. Antioxid. Redox. Signal. 2006, 8, 517-528.
85. Greiwe, J.S.; Cheng, B.; Rubin, D.C.; Yarasheski, K.E.; Semenkovich, C.F. Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J. 2001, 15, 475-482.
86. Menshikova, E.V.; Ritov, V.B.; Fairfull, L.; Ferrell, R.E.; Kelley, D.E.; Goodpaster, B.H. Effects of Exercise on Mitochondrial Content and Function in Aging Human Skeletal Muscle. J. Gerontol. A: Biol. Sci. Med. Sci. 2006, 61, 534-540.
87. Russell, A.P.; Schreiber, S.; Crettenand, A.; Meier, C.A.; Kralli, A.; Deriaz, O. Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferatoractivated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle. Diabetes 2003, 52, 2874-2881.
88. Gleeson, M.; McFarlin, B.; Flynn, M. Exercise and Toll-like receptors. Exerc. Immunol. Rev. 2006, 12, 34-53.
89. Petersen, A.M.; Pedersen, B.K. The anti-inflammatory effect of exercise. J. Appl. Physiol. 2005, 98, 1154-1162.
90. Hameed, M.; Orrell, R.W.; Cobbold, M.; Goldspink, G.; Harridge, S.D. Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J. Physiol. 2003, 547, 247-254.
91. Kosek, D.J.; Kim, J.; Petrella, J.K.; Cross, J.M.; Bamman, M.M. Efficacy of 3 days/wk resistance training on myofiber hypertrophy and myogenic mechanisms in young vs. older adults. J. Appl. Physiol. 2006, 101, 531-544.
92. Melov, S.; Tarnopolsky, M.A.; Beckman, K.; Felkey, K.; Hubbard, A. Resistance exercise reverses aging in human skeletal muscle. PLoS ONE 2007, 2, e465.
93. Sillanpää, E.; Häkkinen, A.; Nyman, K.; Mattila, M.; Cheng, S.; Karavirta, L.; Laaksonen, D.E.; Huuhka, N.; Kraemer, W.J.; Häkkinen, K. Body Composition and Fitness during Strength and/or Endurance Training in Older Men. Med. Sci. Sports Exerc. 2008, 40, 950-958.
94. Nader, G.A. Concurrent strength and endurance training: From molecules to man. Med. Sci. Sports Exerc. 2006, 38, 1965-1970.
95. Atherton, P.J.; Babraj, J.; Smith, K.; Singh, J.; Rennie, M.J.; Wackerhage, H. Selective activation of AMPK-PGC-1alpha or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J. 2005, 19, 786-798.
96. Leeuwenburgh, C.; Wagner, P.; Holloszy, J.O.; Sohal, R.S.; Heinecke, J.W. Caloric restriction attenuates dityrosine cross-linking of cardiac and skeletal muscle proteins in aging mice. Arch. Biochem. Biophys. 1997, 346, 74-80.
97. McKiernan, S.; Bua, E.; McGorray, J.; Aiken, J. Early-onset calorie restriction conserves fiber number in aging rat skeletal muscle. FASEB J. 2004, 18, 580-581.
98. Kim, J.; Kwak, H.; Leeuwenburgh C.; Lawler, J.M. Lifelong Exercise and Mild (8%) Caloric Restriction Attenuate Age-induced Alterations in Plantaris Muscle Morphology, Oxidative Stress and IGF-1 in the Fischer-344 Rat. Exp. Gerontol. 2008, 43, 317-329.
99. Dreyer, H.C.; Volpi, E. Role of protein and amino acids in the pathophysiology and treatment of sarcopenia. J. Am. Coll. Nutr. 2005, 24, 140S-145S.
100. Fujita, S.; Dreyer, H.C.; Drummond, M.J.; Glynn, E.L.; Cadenas, J.G.; Yoshizawa, F.; Volpi, E.; Rasmussen, B.B. Nutrient signalling in the regulation of human muscle protein synthesis. J. Physiol. 2007, 582, 813-823.
101. Karlsson, H.K.; Nilsson, P.A.; Nilsson, J.; Chibalin, A.V.; Zierath, J.R.; Blomstrand, E. Branched-chain amino acids increase p70S6k phosphorylation in human skeletal muscle after resistance exercise. Am. J. Physiol. 2004, 287, E1-E7.
102. Zangarelli, A.; Chanseaume, E.; Morio, B.; Brugère, C.; Mosoni, L.; Rousset, P.; Giraudet, C.; Patrac, V.; Gachon, P.; Boirie, Y.; et al. Synergistic effects of caloric restriction with maintained protein intake on skeletal muscle performance in 21-month-old rats: A mitochondria-mediated pathway. FASEB J. 2006, 20, 2439-2450.